vs

Side-by-side financial comparison of PureCycle Technologies, Inc. (PCT) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

PureCycle Technologies, Inc. is the larger business by last-quarter revenue ($2.7M vs $2.0M, roughly 1.3× Roivant Sciences Ltd.). PureCycle Technologies, Inc. runs the higher net margin — -697.1% vs -13301.2%, a 12604.1% gap on every dollar of revenue. PureCycle Technologies, Inc. produced more free cash flow last quarter ($-42.0M vs $-201.4M).

PureCycle Technologies, Inc. is a sustainable materials firm with proprietary advanced polypropylene recycling technology. It converts contaminated polypropylene waste into high-purity virgin-equivalent resin for use in consumer goods, automotive parts, packaging and industrial products, serving global partners.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

PCT vs ROIV — Head-to-Head

Bigger by revenue
PCT
PCT
1.3× larger
PCT
$2.7M
$2.0M
ROIV
Higher net margin
PCT
PCT
12604.1% more per $
PCT
-697.1%
-13301.2%
ROIV
More free cash flow
PCT
PCT
$159.4M more FCF
PCT
$-42.0M
$-201.4M
ROIV

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
PCT
PCT
ROIV
ROIV
Revenue
$2.7M
$2.0M
Net Profit
$-18.8M
$-265.9M
Gross Margin
Operating Margin
-2196.1%
-16966.1%
Net Margin
-697.1%
-13301.2%
Revenue YoY
-77.8%
Net Profit YoY
71.0%
-257.0%
EPS (diluted)
$-0.14
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PCT
PCT
ROIV
ROIV
Q4 25
$2.7M
$2.0M
Q3 25
$2.4M
$1.6M
Q2 25
$1.6M
$2.2M
Q1 25
$1.6M
$-39.6M
Q4 24
$0
$9.0M
Q3 24
$0
$4.5M
Q2 24
$0
$8.0M
Q1 24
$0
$28.9M
Net Profit
PCT
PCT
ROIV
ROIV
Q4 25
$-18.8M
$-265.9M
Q3 25
$-28.4M
$-113.5M
Q2 25
$-144.2M
$-223.4M
Q1 25
$8.8M
$-206.5M
Q4 24
$-64.7M
$169.4M
Q3 24
$-90.6M
$-230.2M
Q2 24
$-48.2M
$95.3M
Q1 24
$-85.6M
$-151.1M
Operating Margin
PCT
PCT
ROIV
ROIV
Q4 25
-2196.1%
-16966.1%
Q3 25
-1602.2%
-19492.9%
Q2 25
-2763.5%
-13130.0%
Q1 25
-2387.4%
674.8%
Q4 24
-3042.6%
Q3 24
-7636.0%
Q2 24
-1279.5%
Q1 24
-919.5%
Net Margin
PCT
PCT
ROIV
ROIV
Q4 25
-697.1%
-13301.2%
Q3 25
-1167.5%
-7225.9%
Q2 25
-8741.8%
-10292.9%
Q1 25
559.0%
521.8%
Q4 24
1878.3%
Q3 24
-5143.8%
Q2 24
1192.7%
Q1 24
-522.3%
EPS (diluted)
PCT
PCT
ROIV
ROIV
Q4 25
$-0.14
$-0.38
Q3 25
$-0.31
$-0.17
Q2 25
$-0.81
$-0.33
Q1 25
$0.05
$-0.28
Q4 24
$-0.40
$0.23
Q3 24
$-0.54
$-0.31
Q2 24
$-0.29
$0.12
Q1 24
$-0.52
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PCT
PCT
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$156.7M
$4.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$45.9M
$4.3B
Total Assets
$922.7M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PCT
PCT
ROIV
ROIV
Q4 25
$156.7M
$4.5B
Q3 25
$234.4M
$4.4B
Q2 25
$284.1M
$4.5B
Q1 25
$22.5M
$4.9B
Q4 24
$15.7M
$5.1B
Q3 24
$83.7M
$5.4B
Q2 24
$10.9M
$5.7B
Q1 24
$25.0M
$6.5B
Total Debt
PCT
PCT
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
PCT
PCT
ROIV
ROIV
Q4 25
$45.9M
$4.3B
Q3 25
$68.2M
$4.4B
Q2 25
$98.9M
$4.3B
Q1 25
$238.2M
$4.7B
Q4 24
$180.4M
$5.2B
Q3 24
$241.4M
$5.2B
Q2 24
$291.6M
$5.4B
Q1 24
$336.8M
$6.0B
Total Assets
PCT
PCT
ROIV
ROIV
Q4 25
$922.7M
$5.2B
Q3 25
$989.1M
$5.1B
Q2 25
$1.0B
$5.0B
Q1 25
$787.3M
$5.4B
Q4 24
$798.4M
$5.8B
Q3 24
$788.8M
$6.2B
Q2 24
$719.8M
$6.5B
Q1 24
$734.0M
$7.2B
Debt / Equity
PCT
PCT
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PCT
PCT
ROIV
ROIV
Operating Cash FlowLast quarter
$-28.7M
$-196.5M
Free Cash FlowOCF − Capex
$-42.0M
$-201.4M
FCF MarginFCF / Revenue
-1559.6%
-10076.0%
Capex IntensityCapex / Revenue
495.1%
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-183.6M
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PCT
PCT
ROIV
ROIV
Q4 25
$-28.7M
$-196.5M
Q3 25
$-38.5M
$-185.7M
Q2 25
$-36.7M
$-204.4M
Q1 25
$-38.9M
$-172.6M
Q4 24
$-31.8M
$-207.3M
Q3 24
$-33.4M
$-266.8M
Q2 24
$-40.4M
$-192.8M
Q1 24
$-39.2M
$-108.5M
Free Cash Flow
PCT
PCT
ROIV
ROIV
Q4 25
$-42.0M
$-201.4M
Q3 25
$-42.4M
$-193.5M
Q2 25
$-45.3M
$-208.4M
Q1 25
$-53.9M
$-173.4M
Q4 24
$-53.4M
$-209.1M
Q3 24
$-42.6M
$-267.8M
Q2 24
$-50.8M
$-193.8M
Q1 24
$-53.5M
$-108.8M
FCF Margin
PCT
PCT
ROIV
ROIV
Q4 25
-1559.6%
-10076.0%
Q3 25
-1743.1%
-12317.8%
Q2 25
-2747.1%
-9604.5%
Q1 25
-3409.6%
438.1%
Q4 24
-2318.5%
Q3 24
-5984.4%
Q2 24
-2425.5%
Q1 24
-376.1%
Capex Intensity
PCT
PCT
ROIV
ROIV
Q4 25
495.1%
246.9%
Q3 25
160.3%
499.6%
Q2 25
521.5%
185.9%
Q1 25
949.6%
-2.0%
Q4 24
20.3%
Q3 24
22.3%
Q2 24
12.1%
Q1 24
1.2%
Cash Conversion
PCT
PCT
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
-4.40×
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons